Skip to main content
VCbacked
Log inGet Started

Volumina Medical

Epalinges, Switzerland

Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.

$21.0M raised
Mar 2024
Series A
BiotechnologyLife ScienceManufacturingMedical

Top Investors

Venture KickInnosuisseClinique La PrairieFoundation for Innovation and Technology (FIT)EIT Health

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Volumina Medical

How much funding has Volumina Medical raised?
Volumina Medical has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Who are Volumina Medical's investors?
Volumina Medical's investors include Venture Kick, Innosuisse, Clinique La Prairie, Foundation for Innovation and Technology (FIT), EIT Health.
Where is Volumina Medical headquartered?
Volumina Medical is headquartered in Epalinges, Switzerland.
What does Volumina Medical do?
Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.
What stage is Volumina Medical at?
Volumina Medical is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Volumina Medical — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/volumina-medical. Accessed June 4, 2026.
APA
VCBacked. (2024). Volumina Medical — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/volumina-medical
Wikipedia (cite web)
{{cite web |title=Volumina Medical — Funding & Investors |url=https://www.vcbacked.co/company/volumina-medical |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong